Related Experiment Videos
Choosing the right radionuclide and antibody for intraperitoneal radioimmunotherapy
Journal of the National Cancer Institute
|November 20, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases.
The Journal of clinical endocrinology and metabolism·2013
Repeatability of SUV measurements in serial PET.
Medical physics·2011
Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH.
The Journal of clinical endocrinology and metabolism·2011
A novel respiratory tracking system for smart-gated PET acquisition.
Medical physics·2011
Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody.
Physics in medicine and biology·2011
A phase II randomized study of proton therapy vs intensity-modulated radiation therapy in patients with unilateral head and neck cancer.
Journal of the National Cancer Institute·2026
Cancer rarity and mortality: Evidence from a nationwide cohort study.
Journal of the National Cancer Institute·2026
Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.
Journal of the National Cancer Institute·2026
Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.
Journal of the National Cancer Institute·2026
Predictive validity of a 10-item frailty index based on a comprehensive geriatric assessment (FI-CGA-10) in older Japanese adults with cancer.
Journal of the National Cancer Institute·2026
Association between genomic classifier scores and initial management of localized prostate cancer in the United States.
Journal of the National Cancer Institute·2026
Reversing Dysfunction of CCR9+ Regulatory T Cells by Targeting the IL-21/IL-17 Axis Improves Type 1 Diabetes.
Diabetes, metabolic syndrome and obesity : targets and therapy·2026
The Patient With Multiple Alloantibodies: A Systematic Strategy for Antibody Identification and Transfusion Management.
Case reports in immunology·2026